Milestone Pharmaceuticals Inc. (MIST) Financials

MIST Assets vs Liabilities
DateAssetsLiabilities
March 31, 2026 193.7 million 157.7 million
Dec. 31, 2025 113.6 million 71.8 million
Sept. 30, 2025 87.8 million 67.2 million
June 30, 2025 47.4 million 65.2 million

MIST Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
March 31, 2026 -16.1 million 1.3 million
Dec. 31, 2025 -12.8 million 3.6 million
Sept. 30, 2025 -9.8 million 1.3 million
June 30, 2025 -12.6 million 1.3 million

MIST Net Income

No data available :(

MIST Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
March 31, 2026 184.2 million 136.3 million 366000
Dec. 31, 2025 106.0 million 57.2 million 539000
Sept. 30, 2025 82.6 million 56.2 million 519000
June 30, 2025 43.4 million 55.2 million 641000

MIST Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
March 31, 2026 130.3 million
Dec. 31, 2025 83.9 million
Sept. 30, 2025 85.2 million
June 30, 2025 66.4 million

MIST Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
March 31, 2026 44999 3.4 million 4.8 million -
Dec. 31, 2025 11000 5.5 million 13.3 million 8.2 million
Sept. 30, 2025 1982 4.0 million 7.9 million 4.6 million
June 30, 2025 11000 3.7 million 8.9 million 5.1 million

MIST Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
March 31, 2026 238000 70000
Dec. 31, 2025 1.5 million 34000
Sept. 30, 2025 - 24999
June 30, 2025 - 28000

MIST

Price: $1.30

52 week price:
1.00
3.06

Earnings Per Share: -0.64 USD

Exchange: NMS

Sector: Healthcare

Industry: Biotechnology

Country: Canada

Volume: 563278

Market Capitalization: 110.8 million

Links: